Biochemical characterization of PAI-2 and its mutants

Acta Biochimica et Biophysica Sinica

Volumn 32, Issue 2, 2000, Pages 130-132

  Tian, Yu ^a   Shen, Jun Qing ^a   Li, Ping ^a   Zhu, Yun Song ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Expression and purification; Mutation; Plasminogen activator inhibitor type 2

Indexed keywords

EID: 20444420557     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kruithof E K O, Baker M S, Bunn C L. Biological and clinical as-pects of plasminogen activator inhibitor type 2. Blood, 1995, 86: 4007-4024
2. Bachmann F. The enigma PAI-2. Gene expression, evolutionary and functional aspects. Thromb Haemost, 1995, 74: 172-179
3. Dickinson J L, Bates E J, Ferrante A, Antalis T M. Plasminogen activator inhibitor type-2 inhibits tumor necrosis factor α-induced apoptosis. J Biol Chem, 1995, 270(46): 27894-27904
4. Gan H X, Hewman G W, Remold H G. Plasminogen activator inhibitor type-2 prevents programmed cell death of human macrophages infected with Mycobacterium avium. J Immun, 1995, 155: 1304-1315
5. 86, essential for transglutaminase-mediated cross-linking. J Biol Chem, 1994, 269: 15394-15398
6. Jensen P H, Jensen T G, Laug W E, Hager H, Gliemann J, Pepinsky B. The exon 3 encoded sequence of the plasminogen activator inhibitor 2 is a protein binding domain. J Biol Chem, 1996, 271: 26892-26899
7. Melino G, Annicchiarico P M, Piredda L, Candi E, Gentile V, Davies P J, Piacentini M. Tissue transglutaminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol, 1994, 14: 6584-6596
8. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A laboratory Manual, Beijing: Science Press, 1992, 880-887
9. Tian Y, Shen J Q, Li P, Song H Y, Zhu Y S. Expression and purification of human plasminogen activator inhibitor type 2 in E. coli. Chin J Biochem Mol Biol, 1998, 14(5): 536-541
10. Michiyasu I et al. Purification and refolding of recombinant human proMMP-7(pro-Matrilysin) expressed in Escherichia coli and its characterization. J Biochem, 1996, 119: 667-673
11. Peter M et al. Plasminogen activator inhibitor type 2 (PAI-2): A spontaneously polymerizing SERPIN. Eur J Biochem, 1993, 218: 1071-1082
12. Baker M S, Green S P, Goss N, Katrantzis M, Doe W F. Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils. Biochem Biophys Res Comm, 1990, 166: 993-1000
13. Sixtus T et al. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2. Eur J Biochem, 1988, 175: 33-39
14. Kiso U, Kaudewitz H, Henschen A, Astedt B, Kruithof E K, Bachmann F. Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type-2 and urokinases. FEBS Lett, 1988, 230: 51-56
15. Jensen P H, Lorand L, Ebbesen P, Gliemann J. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor VIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur J Biochem, 1993, 214: 141-147
16. Loskutoff D J, van Mourik J A, Erickson L A, Lawrence D. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci USA, 1983, 80: 2956-2960
17. Wang J Y, Jia H Y, Song H Y. Determination of the activity of tissue-type plasminogen activator and its inhibitor in human plasma. Chin J Med Lab Sci, 1989, 12(3): 163-167
18. Lai L H. Prediction of Protein Structure and the Principles of Protein Conformation, Beijing: Peking University Press, 1993, 22-23
19. Tian Y, Shen J Q, Cai X Y, Li P, Song H Y, Zhu Y S. Purification and biochemical characteristics of human plasminogen activator inhibitor type 2 expressed in E. coli. J Shanghai Med Univ, 1998, 25(3): 1-5
20. Remold O'Donnell E. The ovalbumin family of serpin proteins. FEBS Lett, 1993, 315: 105-108